361 related articles for article (PubMed ID: 19318226)
1. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo.
Smiałowska M; Domin H; Zieba B; Koźniewska E; Michalik R; Piotrowski P; Kajta M
Neuropeptides; 2009 Jun; 43(3):235-49. PubMed ID: 19318226
[TBL] [Abstract][Full Text] [Related]
2. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
3. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats.
Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
Neuroscience; 2017 Mar; 344():305-325. PubMed ID: 28057538
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus.
Smiałowska M; Wierońska JM; Szewczyk B
Pol J Pharmacol; 2003; 55(6):979-86. PubMed ID: 14730092
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity.
Wu YF; Li SB
Acta Pharmacol Sin; 2005 Jan; 26(1):63-8. PubMed ID: 15659116
[TBL] [Abstract][Full Text] [Related]
7. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures.
Silva AP; Pinheiro PS; Carvalho AP; Carvalho CM; Jakobsen B; Zimmer J; Malva JO
FASEB J; 2003 Jun; 17(9):1118-20. PubMed ID: 12692082
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
9. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
[TBL] [Abstract][Full Text] [Related]
11. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
12. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
15. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.
Xapelli S; Bernardino L; Ferreira R; Grade S; Silva AP; Salgado JR; Cavadas C; Grouzmann E; Poulsen FR; Jakobsen B; Oliveira CR; Zimmer J; Malva JO
Eur J Neurosci; 2008 Apr; 27(8):2089-102. PubMed ID: 18412629
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors.
Alvaro AR; Rosmaninho-Salgado J; Ambrósio AF; Cavadas C
J Neurochem; 2009 Jun; 109(5):1508-15. PubMed ID: 19344373
[TBL] [Abstract][Full Text] [Related]
17. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
19. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
